Market Overview

Mylan Recalls Birth Control Product Freya-28 in Canada

Freya-28, an oral contraceptive (birth control product), is being voluntarily recalled from the Canadian market by Mylan Pharmaceuticals (NYSE: MYL) after a pharmacy reported that a placebo pill was found in place of an active pill in one package. Packages of Freya-28 (see pictures below) should have three rows of active (white) pills and one row of placebo (green) pills.Missing one or more active (white) pills could result in reduced effectiveness for contraception, with the possibility of an unplanned pregnancy. As of August 15, 2013, there had been no adverse reactions reported to Mylan Pharmaceuticals.Who is affected:Canadians who have purchased or used these products.What consumers should do:- Consult your healthcare practitioner with any questions or concerns regarding the use of oral contraceptives, especially Freya-28.- Use a non-hormonal method of birth control (such as condoms, spermicidal foam or gel) until another oral contraceptive can be obtained. - Return unopened packages to their pharmacist.- Report any adverse reactions potentially related to Freya-28 to Health Canada.- Contact Health Canada's toll-free line at 1-800-267-9675 with questions or complaints about this product.What Health Canada is doing:As of August 27, 2013, the manufacturer, Mylan Pharmaceuticals, had been informed of

See full press release

Posted-In: News Guidance Contracts Asset Sales Management Global

 

Related Articles (MYL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional